ACA
ONC icon

Atlas Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Atlas Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,125
Closed -$212K – 1033
2022
Q1 		$212K Sell
1,125
-37
-3% -$7.87K 0.03% 340
2021
Q4 		$315K Hold
1,162
– – 0.05% 292
2021
Q3 		$422K Sell
1,162
-109
-9% -$35.6K 0.07% 227
2021
Q2 		$436K Hold
1,271
– – 0.07% 233
2021
Q1 		$442K Hold
1,271
– – 0.09% 218
2020
Q4 		$328K Sell
1,271
-195
-13% -$53.7K 0.07% 241
2020
Q3 		$420K Sell
1,466
-71
-5% -$16.7K 0.1% 206
2020
Q2 		$290K Sell
1,537
-51
-3% -$8.3K 0.07% 261
2020
Q1 		$195K Buy
1,588
+148
+10% +$23.1K 0.06% 273
2019
Q4 		$239K Sell
1,440
-46
-3% -$7.64K 0.06% 292
2019
Q3 		$182K Buy
1,486
+1,386
+1,386% +$184K 0.05% 332
2019
Q2 		$12.4K Hold
100
– – ﹤0.01% 587
2019
Q1 		$13.2K Buy
+100
New +$13.5K ﹤0.01% 514

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Atlas Capital Advisors's ONC Position: Q2 2022 in Review

Atlas Capital Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 1,125 shares — an estimated $212K sold.

Atlas Capital Advisors first reported a position in ONC in Q1 2019 and held it in 13 quarters. The position peaked at $442K in Q1 2021. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • Atlas Capital Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • Atlas Capital Advisors sold 1,125 BeOne Medicines Ltd shares in Q2 2022, an estimated $212K.
  • Atlas Capital Advisors first reported a position in BeOne Medicines Ltd in Q1 2019 and held it in 13 quarters.
  • Atlas Capital Advisors's BeOne Medicines Ltd position peaked at $442K in Q1 2021.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Atlas Capital Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.